Point72 Asset Management L.P. Purchases Shares of 4,728,497 Haleon plc (NYSE:HLN)

Point72 Asset Management L.P. bought a new stake in Haleon plc (NYSE:HLN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,728,497 shares of the company's stock, valued at approximately $45,110,000. Point72 Asset Management L.P. owned about 0.10% of Haleon as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the company. Sierra Ocean LLC purchased a new stake in shares of Haleon in the 4th quarter worth about $26,000. Geneos Wealth Management Inc. purchased a new stake in shares of Haleon in the fourth quarter valued at about $35,000. Spire Wealth Management acquired a new stake in shares of Haleon in the fourth quarter valued at approximately $39,000. FIL Ltd increased its stake in shares of Haleon by 45.7% during the 4th quarter. FIL Ltd now owns 4,049 shares of the company's stock worth $39,000 after purchasing an additional 1,270 shares in the last quarter. Finally, Addison Advisors LLC increased its stake in shares of Haleon by 28.7% during the 4th quarter. Addison Advisors LLC now owns 4,954 shares of the company's stock worth $47,000 after purchasing an additional 1,106 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Trading Up 0.8%

Shares of NYSE:HLN traded up $0.09 during midday trading on Monday, reaching $10.89. The company's stock had a trading volume of 13,701,832 shares, compared to its average volume of 8,030,194. The firm has a market cap of $49.09 billion, a price-to-earnings ratio of 32.03, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. The business has a 50 day moving average price of $10.22 and a 200 day moving average price of $9.86. Haleon plc has a 1 year low of $8.25 and a 1 year high of $10.90. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The company had revenue of $3.54 billion during the quarter, compared to analysts' expectations of $3.38 billion. Research analysts forecast that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The business also recently declared a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be given a dividend of $0.1166 per share. This is a positive change from Haleon's previous -- dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. Haleon's dividend payout ratio is 58.97%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Barclays restated an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Morgan Stanley raised Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a research note on Friday, May 9th. Hsbc Global Res downgraded shares of Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 5th. Finally, HSBC restated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Five analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $11.25.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.